These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25111404)

  • 21. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of the use of a transdermal fentanyl patch in cats.
    Scherk-Nixon M
    J Am Anim Hosp Assoc; 1996; 32(1):19-24. PubMed ID: 8963731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R; Nuijten M; Nautrup BP
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Three-day-type transdermal fentanyl patch conversion by rapid titration method with short-acting oral oxycodone for cancer pain].
    Yamazaki K; Fujio N; Ishikawa N; Watanabe H; Kameyama M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):405-8. PubMed ID: 22421768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low doses of transdermal fentanyl in opioid-naive patients with cancer pain.
    Mercadante S; Porzio G; Ferrera P; Aielli F; Adile C; Ficorella C
    Curr Med Res Opin; 2010 Dec; 26(12):2765-8. PubMed ID: 21034376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fentanyl tolerance in the treatment of cancer pain: a case of successful opioid switching from fentanyl to oxycodone at a reduced equivalent dose.
    Sutou I; Nakatani T; Hashimoto T; Saito Y
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):161-5. PubMed ID: 26095488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of the clinical trial of transdermal therapeutic system-fentanyl in strong opioid pre-treated adult patients with cancer-related pain.
    Besova N; Gorbounova V; Saltanov A; Zarouk V
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():378-84. PubMed ID: 10895182
    [No Abstract]   [Full Text] [Related]  

  • 29. Transdermal fentanyl for chronic pain.
    Pasero CL; McCaffery M
    Am J Nurs; 1997 Nov; 97(11):17-8. PubMed ID: 9372703
    [No Abstract]   [Full Text] [Related]  

  • 30. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain.
    Kress HG; Von der Laage D; Hoerauf KH; Nolte T; Heiskanen T; Petersen R; Lundorff L; Sabatowski R; Krenn H; Rosland JH; Saedder EA; Jensen NH
    J Pain Symptom Manage; 2008 Sep; 36(3):268-79. PubMed ID: 18538974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A successful switch from transdermal fentanyl to transdermal buprenorphine in a patient with neuropathic pain: a case report.
    Leppert W
    Am J Hosp Palliat Care; 2014 Feb; 31(1):101-4. PubMed ID: 23349342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid switching between transdermal fentanyl and methadone in cancer patients.
    Mercadante S; Ferrera P; Villari P; Casuccio A
    J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pitfall to avoid when starting a patient on transdermal fentanyl.
    Low JA; Chye R
    Aust Fam Physician; 2000 Dec; 29(12):1173-5. PubMed ID: 11140227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain.
    Kornick CA; Santiago-Palma J; Schulman G; O'Brien PC; Weigand S; Payne R; Manfredi PL
    Cancer; 2003 Jun; 97(12):3121-4. PubMed ID: 12784350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rifampin reduces the analgesic effect of transdermal fentanyl.
    Takane H; Nosaka A; Wakushima H; Hosokawa K; Ieiri I
    Ann Pharmacother; 2005 Dec; 39(12):2139-40. PubMed ID: 16288064
    [No Abstract]   [Full Text] [Related]  

  • 36. What is your gut feeling about opioid rotation?
    Didwaniya N; Reddy A; Gottumukkala RS; Bruera E
    J Clin Oncol; 2015 Jan; 33(3):e11-2. PubMed ID: 24590650
    [No Abstract]   [Full Text] [Related]  

  • 37. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Opioid intoxication. Inappropriate administration of transdermal fentanyl].
    Klockgether-Radke A; Hildebrandt J
    Anaesthesist; 1997 May; 46(5):428-9. PubMed ID: 9245212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-use evaluation of transdermal fentanyl.
    Shamilian A
    Am J Health Syst Pharm; 1995 Nov; 52(22):2597-8. PubMed ID: 8590247
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of long-term, high-dose transdermal fentanyl application for lung cancer pain].
    Kamiya N; Yasogawa Y; Nishi Y; Takahashi Y; Kondo Y; Hirai T; Sakurai M; Masumizu K; Onosato W; Koyama T
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):377-80. PubMed ID: 16531723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.